122 related articles for article (PubMed ID: 10417535)
1. Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: the anti-230-kDa autoantibody is not synthesized by leukaemic cells.
Misery L; Cambazard F; Rimokh R; Ghohestani R; Magaud JP; Gaudillere A; Perrot JL; Berard F; Claudy A; Guyotat D; Schmitt D; Vincent C
Br J Dermatol; 1999 Jul; 141(1):155-7. PubMed ID: 10417535
[No Abstract] [Full Text] [Related]
2. Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag).
Ghohestani R; Nicolas JF; Kanitakis J; Bedane C; Faure M; Claudy A
Br J Dermatol; 1996 Mar; 134(3):603-4. PubMed ID: 8731696
[No Abstract] [Full Text] [Related]
3. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
Ghohestani RF; Claudy A
Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
[No Abstract] [Full Text] [Related]
4. The role of bullous pemphigoid antibodies in dermal-epidermal separation.
Haustein UF
J Invest Dermatol; 1989 Jan; 92(1):133. PubMed ID: 2642509
[No Abstract] [Full Text] [Related]
5. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
Huang MX; Li ZS; Luo DQ; Lin Q
G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
[No Abstract] [Full Text] [Related]
7. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
Korman NJ; Stanley JR; Woodley DT
Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
[TBL] [Abstract][Full Text] [Related]
10. Bullous pemphigoid associated with Shy-Drager syndrome.
Okazaki A; Iida T; Muramatsu T; Shirai T; Murata K; Takayanagi T
J Dermatol; 1998 Jul; 25(7):465-8. PubMed ID: 9714981
[TBL] [Abstract][Full Text] [Related]
11. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5.
Kawahara Y; Amagai M; Ohata Y; Ishii K; Hasegawa Y; Hsu R; Yee C; Yancey KB; Nishikawa T
J Am Acad Dermatol; 1998 Apr; 38(4):624-7. PubMed ID: 9555805
[No Abstract] [Full Text] [Related]
12. Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid.
Sami N; Ali S; Bhol KC; Ahmed AR
J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):641-5. PubMed ID: 14761129
[TBL] [Abstract][Full Text] [Related]
13. [Bullous pemphigoid].
Ohyama M; Amagai M
Ryoikibetsu Shokogun Shirizu; 2000; (31):274-6. PubMed ID: 11269078
[No Abstract] [Full Text] [Related]
14. Bullous pemphigoid antibodies.
Accetta PJ; Tarfare N; Helm F; Beutner EH
Arch Dermatol; 1986 May; 122(5):505. PubMed ID: 3085598
[No Abstract] [Full Text] [Related]
15. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
16. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
[No Abstract] [Full Text] [Related]
17. Immune complex and complement-mediated leukocyte recruitment in bullous pemphigoid.
Gammon WR
Immunol Ser; 1989; 46():509-25. PubMed ID: 2488868
[No Abstract] [Full Text] [Related]
18. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological factors associated with bullous pemphigoid relapse.
Fine JD
JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
[No Abstract] [Full Text] [Related]
20. Bullous pemphigoid and other basement membrane antigens.
Diaz LA; Anhalt GJ
Clin Dermatol; 1987; 5(1):93-109. PubMed ID: 3552197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
